Patil Neena M's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Mar 3, 2025
- Accession no.
- 0001765581-25-000008
- Filed
- Mar 3, 2025
- Trade date
- Feb 27, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $550.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patil Neena MCIK 0001783908 | Officer (EVP & Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Ordinary Shares | SSaleDisposed | −3,800 | $144.87F1 | −$550,506 | 33,318 | Direct | |
| Feb 27, 2025 | Ordinary Shares | AGrant or awardAcquired | +12,518 | $0.00 | $0 | 45,836 | Direct | |
| Feb 27, 2025 | Ordinary Shares | AGrant or awardAcquired | +5,778 | $0.00 | $0 | 51,614 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.81 to $144.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.